Table of Contents
Global Age Related Macular Degeneration Drug Market Professional Survey Report 2021
1 Industry Overview of Age Related Macular Degeneration Drug
1.1 Definition and Specifications of Age Related Macular Degeneration Drug
1.1.1 Definition of Age Related Macular Degeneration Drug
1.1.2 Specifications of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
1.2.1 Lucentis
1.2.2 Eylea
1.2.3 Avastin
1.2.4 Others
1.3 Applications of Age Related Macular Degeneration Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
2.4 Industry Chain Structure of Age Related Macular Degeneration Drug
3 Technical Data and Manufacturing Plants Analysis of Age Related Macular Degeneration Drug
3.1 Capacity and Commercial Production Date of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
4 Global Age Related Macular Degeneration Drug Overall Market Overview
4.1 2016 - 2021E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2016 - 2021E Global Age Related Macular Degeneration Drug Capacity and Growth Rate Analysis
4.2.2 2017 Age Related Macular Degeneration Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2016 - 2021E Global Age Related Macular Degeneration Drug Sales and Growth Rate Analysis
4.3.2 2017 Age Related Macular Degeneration Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2016 - 2021E Global Age Related Macular Degeneration Drug Sales Price
4.4.2 2017 Age Related Macular Degeneration Drug Sales Price Analysis (Company Segment)
5 Age Related Macular Degeneration Drug Regional Market Analysis
5.1 North America Age Related Macular Degeneration Drug Market Analysis
5.1.1 North America Age Related Macular Degeneration Drug Market Overview
5.1.2 North America 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.1.4 North America 2017 Age Related Macular Degeneration Drug Market Share Analysis
5.2 Europe Age Related Macular Degeneration Drug Market Analysis
5.2.1 Europe Age Related Macular Degeneration Drug Market Overview
5.2.2 Europe 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.2.4 Europe 2017 Age Related Macular Degeneration Drug Market Share Analysis
5.3 China Age Related Macular Degeneration Drug Market Analysis
5.3.1 China Age Related Macular Degeneration Drug Market Overview
5.3.2 China 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.3.4 China 2017 Age Related Macular Degeneration Drug Market Share Analysis
5.4 Japan Age Related Macular Degeneration Drug Market Analysis
5.4.1 Japan Age Related Macular Degeneration Drug Market Overview
5.4.2 Japan 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.4.4 Japan 2017 Age Related Macular Degeneration Drug Market Share Analysis
5.5 Southeast Asia Age Related Macular Degeneration Drug Market Analysis
5.5.1 Southeast Asia Age Related Macular Degeneration Drug Market Overview
5.5.2 Southeast Asia 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.5.4 Southeast Asia 2017 Age Related Macular Degeneration Drug Market Share Analysis
5.6 India Age Related Macular Degeneration Drug Market Analysis
5.6.1 India Age Related Macular Degeneration Drug Market Overview
5.6.2 India 2016 - 2021E Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2016 - 2021E Age Related Macular Degeneration Drug Sales Price Analysis
5.6.4 India 2017 Age Related Macular Degeneration Drug Market Share Analysis
6 Global 2016 - 2021E Age Related Macular Degeneration Drug Segment Market Analysis (by Type)
6.1 Global 2016 - 2021E Age Related Macular Degeneration Drug Sales by Type
6.2 Different Types of Age Related Macular Degeneration Drug Product Interview Price Analysis
6.3 Different Types of Age Related Macular Degeneration Drug Product Driving Factors Analysis
6.3.1 Lucentis of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
6.3.2 Eylea of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
6.3.3 Avastin of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
6.3.4 Others of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
7 Global 2016 - 2021E Age Related Macular Degeneration Drug Segment Market Analysis (by Application)
7.1 Global 2016 - 2021E Age Related Macular Degeneration Drug Consumption by Application
7.2 Different Application of Age Related Macular Degeneration Drug Product Interview Price Analysis
7.3 Different Application of Age Related Macular Degeneration Drug Product Driving Factors Analysis
7.3.1 Clinic of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
7.3.2 Hospital of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
7.3.3 Others of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Age Related Macular Degeneration Drug
8.1 Applied Genetic Technologies Corp
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Applied Genetic Technologies Corp 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.1.4 Applied Genetic Technologies Corp 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.2 Astellas Pharma Inc
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Astellas Pharma Inc 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.2.4 Astellas Pharma Inc 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.3 Benitec Biopharma Ltd
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Benitec Biopharma Ltd 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.3.4 Benitec Biopharma Ltd 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.4 Biokine Therapeutics Ltd
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Biokine Therapeutics Ltd 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.4.4 Biokine Therapeutics Ltd 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.5 Crinetics Pharmaceuticals Inc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Crinetics Pharmaceuticals Inc 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.5.4 Crinetics Pharmaceuticals Inc 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.6 Critical Pharmaceuticals Ltd
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Critical Pharmaceuticals Ltd 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.6.4 Critical Pharmaceuticals Ltd 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.7 Daiichi Sankyo Company Ltd
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Daiichi Sankyo Company Ltd 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.7.4 Daiichi Sankyo Company Ltd 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.8 Diffusion Pharmaceuticals Inc
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Diffusion Pharmaceuticals Inc 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.8.4 Diffusion Pharmaceuticals Inc 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.9 Dong - A Socio Holdings Co Ltd
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Dong - A Socio Holdings Co Ltd 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.9.4 Dong - A Socio Holdings Co Ltd 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.10 Eleven Biotherapeutics Inc
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Eleven Biotherapeutics Inc 2017 Age Related Macular Degeneration Drug Sales, Ex - factory Price, Revenue, Gross Margin Analysis
8.10.4 Eleven Biotherapeutics Inc 2017 Age Related Macular Degeneration Drug Business Region Distribution Analysis
8.11 Elsalys Biotech SAS
8.12 Lupin Ltd
8.13 M's Science Corp
8.14 Mabion SA
8.15 MacuCLEAR Inc
9 Development Trend of Analysis of Age Related Macular Degeneration Drug Market
9.1 Global Age Related Macular Degeneration Drug Market Trend Analysis
9.1.1 Global 2021 - 2027 Age Related Macular Degeneration Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2021 - 2027 Age Related Macular Degeneration Drug Sales Price Forecast
9.2 Age Related Macular Degeneration Drug Regional Market Trend
9.2.1 North America 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.2.2 Europe 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.2.3 China 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.2.4 Japan 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.2.5 Southeast Asia 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.2.6 India 2021 - 2027 Age Related Macular Degeneration Drug Consumption Forecast
9.3 Age Related Macular Degeneration Drug Market Trend (Product Type)
9.4 Age Related Macular Degeneration Drug Market Trend (Application)
10 Age Related Macular Degeneration Drug Marketing Type Analysis
10.1 Age Related Macular Degeneration Drug Regional Marketing Type Analysis
10.2 Age Related Macular Degeneration Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Age Related Macular Degeneration Drug by Region
10.4 Age Related Macular Degeneration Drug Supply Chain Analysis
11 Consumers Analysis of Age Related Macular Degeneration Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Age Related Macular Degeneration Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Age Related Macular Degeneration Drug
Table Product Specifications of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2017
Figure Lucentis Picture
Table Major Manufacturers of Lucentis
Figure Eylea Picture
Table Major Manufacturers of Eylea
Figure Avastin Picture
Table Major Manufacturers of Avastin
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Age Related Macular Degeneration Drug
Figure Global Consumption Volume Market Share of Age Related Macular Degeneration Drug by Application in 2017
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Age Related Macular Degeneration Drug by Regions
Figure North America Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Figure Europe Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Figure China Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Figure Japan Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Figure Southeast Asia Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Figure India Age Related Macular Degeneration Drug Market Size (Million USD) (2016 - 2027)
Table Age Related Macular Degeneration Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug in 2017
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Industry Chain Structure of Age Related Macular Degeneration Drug
Table Capacity and Commercial Production Date of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Age Related Macular Degeneration Drug Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Age Related Macular Degeneration Drug 2016 - 2021E
Figure Global 2016 - 2021E Age Related Macular Degeneration Drug Market Size (Volume) and Growth Rate
Figure Global 2016 - 2021E Age Related Macular Degeneration Drug Market Size (Value) and Growth Rate
Table 2016 - 2021E Global Age Related Macular Degeneration Drug Capacity and Growth Rate
Table 2017 Global Age Related Macular Degeneration Drug Capacity (K Pcs) List (Company Segment)
Table 2016 - 2021E Global Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate
Table 2017 Global Age Related Macular Degeneration Drug Sales (K Pcs) List (Company Segment)
Table 2016 - 2021E Global Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Table 2017 Global Age Related Macular Degeneration Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure North America 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure North America 2017 Age Related Macular Degeneration Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure Europe 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure Europe 2017 Age Related Macular Degeneration Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure China 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure China 2017 Age Related Macular Degeneration Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure Japan 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure Japan 2017 Age Related Macular Degeneration Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure Southeast Asia 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2017 Age Related Macular Degeneration Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Age Related Macular Degeneration Drug 2016 - 2021E
Figure India 2016 - 2021E Age Related Macular Degeneration Drug Sales Price (USD/Pcs)
Figure India 2017 Age Related Macular Degeneration Drug Sales Market Share
Table Global 2016 - 2021E Age Related Macular Degeneration Drug Sales (K Pcs) by Type
Table Different Types Age Related Macular Degeneration Drug Product Interview Price
Table Global 2016 - 2021E Age Related Macular Degeneration Drug Sales (K Pcs) by Application
Table Different Application Age Related Macular Degeneration Drug Product Interview Price
Table Applied Genetic Technologies Corp Information List
Table Product A Overview
Table Product B Overview
Table 2017 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue (Million USD), Sales (K Pcs), Ex - factory Price (USD/Pcs)
Figure 2017 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Business Region Distribution
Table Astellas Pharma Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue (Million USD), Sales (K Pcs), Ex - factory Price (USD/Pcs)
Figure 2017 Astellas Pharma Inc Age Related Macular Degeneration Drug Business Region Distribution
Table Benitec Biopharma Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2015 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue (Million USD), Sales (K Pcs), Ex - factory Price (USD/Pcs)
Figure 2017 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Business Region Distribution
Table Biokine Therapeutics Ltd I
